Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Magnetic Resonance Imaging"
DOI: 10.1002/jmri.28333
Abstract: MRI‐targeted biopsy (MRTB) improves the clinically significant prostate cancer (csPCa) detection rate with fewer biopsy cores in men with suspected PCa. However, whether concurrent systematic biopsy (SB) can be avoided in patients undergoing MRTB remains… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Journal of Magnetic Resonance Imaging"
DOI: 10.1002/jmri.29653
Abstract: Multiparametric MRI may cause overdiagnosis of clinically significant prostate cancer (csPCa) with the Prostate Imaging Reporting and Data System version 2.1 (PI‐RADS v2.1). read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Journal of Medical Radiation Sciences"
DOI: 10.1002/jmrs.841
Abstract: Accurate identification and grading of clinically significant prostate cancer (csPCa, Gleason Score ≥ 7) without invasive procedures remains a significant clinical challenge. This study aims to develop and evaluate a two‐stage model designed for precise Gleason grading.… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "World Journal of Urology"
DOI: 10.1007/s00345-024-04991-6
Abstract: Purpose mpMRI is routinely used to stratify the risk of clinically significant prostate cancer (csPCa) in men with elevated PSA values before biopsy. This study aimed to calculate a multivariable risk model incorporating standard risk… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Japanese Journal of Radiology"
DOI: 10.1007/s11604-018-0801-9
Abstract: PurposeTo clarify clinicopathological features of false-negative clinically significant prostate cancer (csPC) at multiparametric prostate MRI (mpMRI).Methods95 patients with 139 csPC undergoing 3T mpMRI before radical prostatectomy were included. Two radiologists were independently evaluated mpMR images… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Canadian Association of Radiologists Journal"
DOI: 10.1016/j.carj.2019.07.005
Abstract: Introduction To establish the diagnostic performance of the parameters obtained from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging at 3T in discriminating between non-clinically significant prostate cancers (ncsPCa, Gleason score [GS] < 7)… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "European journal of radiology"
DOI: 10.1016/j.ejrad.2018.01.028
Abstract: BACKGROUND MRI plays a crucial role to identify men with a high likelihood of clinically significant prostate cancer who require immediate biopsy. The added value of DCE MRI in combination with T2-weighted imaging and DWI… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "European journal of radiology"
DOI: 10.1016/j.ejrad.2019.05.006
Abstract: PURPOSE Prostate multiparametric MRI (mpMRI) is the imaging modality of choice for detecting clinically significant prostate cancer (csPCa). Among various parameters, lesion maximum diameter and volume are currently considered of value to increase diagnostic accuracy.… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "Heliyon"
DOI: 10.1016/j.heliyon.2021.e08325
Abstract: Background We assessed the 5-year risk of being diagnosed with significant prostate cancer following a low-suspicion biparametric magnetic resonance imaging result. Methods The study population was derived from a prospective database used to assess the… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Urology"
DOI: 10.1016/j.urology.2018.06.020
Abstract: OBJECTIVE To compare detection rates of clinically significant prostate cancer (Gleason 7 or above) between standard transrectal ultrasound guided biopsy (TRUSGB) and software-assisted systematic biopsy (SASB) using magnetic resonance/ultrasound fusion in the setting of negative… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-76786-9
Abstract: The purpose of this study was to assess the predictive value of prostate specific antigen density (PSAD) for detection of clinically significant prostate cancer in men undergoing systematic transrectal ultrasound (TRUS)-guided prostate biopsy. We retrospectively… read more here.